Correlation Between Atea Pharmaceuticals and Recursion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Atea Pharmaceuticals and Recursion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atea Pharmaceuticals and Recursion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atea Pharmaceuticals and Recursion Pharmaceuticals, you can compare the effects of market volatilities on Atea Pharmaceuticals and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atea Pharmaceuticals with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atea Pharmaceuticals and Recursion Pharmaceuticals.
Diversification Opportunities for Atea Pharmaceuticals and Recursion Pharmaceuticals
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Atea and Recursion is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Atea Pharmaceuticals and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and Atea Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atea Pharmaceuticals are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of Atea Pharmaceuticals i.e., Atea Pharmaceuticals and Recursion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Atea Pharmaceuticals and Recursion Pharmaceuticals
Given the investment horizon of 90 days Atea Pharmaceuticals is expected to generate 0.57 times more return on investment than Recursion Pharmaceuticals. However, Atea Pharmaceuticals is 1.76 times less risky than Recursion Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Recursion Pharmaceuticals is currently generating about -0.12 per unit of risk. If you would invest 342.00 in Atea Pharmaceuticals on August 28, 2024 and sell it today you would lose (2.00) from holding Atea Pharmaceuticals or give up 0.58% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Atea Pharmaceuticals vs. Recursion Pharmaceuticals
Performance |
| Timeline |
| Atea Pharmaceuticals |
| Recursion Pharmaceuticals |
Atea Pharmaceuticals and Recursion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Atea Pharmaceuticals and Recursion Pharmaceuticals
The main advantage of trading using opposite Atea Pharmaceuticals and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atea Pharmaceuticals position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.| Atea Pharmaceuticals vs. Immix Biopharma | Atea Pharmaceuticals vs. Cns Pharmaceuticals | Atea Pharmaceuticals vs. Hepion Pharmaceuticals | Atea Pharmaceuticals vs. Enveric Biosciences |
| Recursion Pharmaceuticals vs. Eliem Therapeutics | Recursion Pharmaceuticals vs. HCW Biologics | Recursion Pharmaceuticals vs. Scpharmaceuticals | Recursion Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |